September 8, 2023

European Urology Focus publishes an update on the EA8212 (BRIDGE) trial for early bladder cancer

August 3, 2023

Dr. Barbara Burtness, Head and Neck Cancer Committee Chair, on a new way to classify HPV-associated head and neck cancers

August 3, 2023

AACR’s Clinical Cancer Research publishes a review article, “The New NCI Precision Medicine Trials”

August 3, 2023

Researchers identify two new subtypes of HPV-associated head and neck cancers

July 31, 2023

Proceedings of the National Academy of Sciences publishes the discovery of two new subtypes of HPV-associated head and neck cancers

June 16, 2023

Media Advisory: Nature Medicine publishes key lessons from NCI-MATCH to guide future precision medicine trials

June 1, 2023

Press Release: ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials

May 30, 2023

Group leaders talk with The Cancer Letter about the cisplatin chemotherapy shortage (login required)

April 21, 2023

Lancet Digital Health publishes the first validation of a CT-based deep learning tool for pre-treatment identification of head and neck cancer patients with high-risk, aggressive disease (in the context of the E3311 trial)

ECOG-ACRIN Cancer Research Group